Skip to main content

Day: December 26, 2019

Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

HINGHAM, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with certain institutional investors for the purchase in a registered direct offering of 912,858 shares of its common stock, at a purchase price per share of $10.50, priced at-the-market under Nasdaq rules.The closing of the offering is expected to occur on or about December 27, 2019, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds to Microbot, before deducting placement agent fees and other offering expenses, are expected to be approximately $9.59...

Continue reading

Spring Bank Stops Dosing of Inarigivir Patients in Phase 2 Program

HOPKINTON, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that the company has stopped dosing and enrolling patients in its Phase 2b CATALYST trials, which are examining the use of inarigivir soproxil 400mg for the treatment of chronic hepatitis B virus (HBV). In addition, the company has stopped dosing and enrollment in all other studies of inarigivir in subjects with chronic HBV.The decision to stop the dosing of inarigivir 400mg in the Phase 2b CATALYST trials was due to clinical findings observed in the CATALYST 2 trial of virally-suppressed chronic HBV patients. Laboratory findings revealed that three subjects participating...

Continue reading

Velcan Holdings: Share buyback program – weekly statement

Luxembourg, 26th December 2019SHARES REPURCHASE PROGRAMMEAuthorized by the shareholders’ meeting held on 28th June 2017Implemented upon the decision of the Board of Directors dated 13th December 2019DISCLOSURE OF PURCHASESEFFECTED FROM 17th DECEMBER 2019 to 24th DECEMBER 2019Market: Euronext Growth ParisType of shares: ordinary shares ISIN FR0010245803Repurchase programme full description dated 17th December 2019 is available on Velcan Holdings website*          *          *Regulatory information available on                      www.velcan.luInvestor Relations Contact                                        ...

Continue reading

Aéroports de Paris SA- Announcement of the compensation for the loss of Atatürk airport

Financial release26 December 2019Aéroports de Paris SAGroupe ADP welcomes the announcement by Turkish authorities of the compensation due to TAV Airports for the early closure ofAtatürk airportTAV Airports received an official notification letter with the amount of the compensation for the loss of profit for the early closure of Istanbul Atatürk airport, from the Turkish National Airports Authority (“DHMI”).TAV Istanbul had the right to operate, in application of a contract of lease signed with the National Airports Authority (“DHMI”), the national and international airport of Atatürk, the car park and the general aviation terminal for 15 and a half years, from 03/07/2005 at 00:01 to 02/01/2021 at 24:00 hours. Following a decision by the Turkish authorities, all commercial flights were transferred...

Continue reading

Aéroports de Paris SA – Annonce de l’indemnisation pour la perte d’Atatürk

COMMUNIQUE DE PRESSETremblay-en-France, le 26 décembre 2019Aéroports de Paris SAGroupe ADP se félicite de la notification par les autorités turques de l’indemnisation due à TAV Airports pour fermeture anticipée de l’aéroport d’AtatürkTAV Airports a reçu une lettre de notification formelle du montant de la compensation du manque à gagner due à l’expiration anticipée de l’aéroport d’Istanbul Atatürk, de la part de l’Autorité Nationale des Transports Turque (“DHMI”).TAV Istanbul avait le droit d’exploiter, en application d’un contrat conclu avec l’Autorité Nationale des Aéroports (“DHMI”), l’aéroport national et international d’Atatürk,...

Continue reading

RADA reports Nomination of a new director, Mr. Joseph Weiss

NETANYA, Israel, Dec. 26, 2019 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (the “Company”) announced that its Board of Directors (the “Board”) has appointed Joseph Weiss to the Board, with immediate effective. Mr. Weiss, from 2012 to 2018, served as the President and Chief Executive Officer of Israel Aerospace Industries Ltd (“IAI”), Israel’s largest aerospace corporation and the country’s largest high-tech company. IAI is a world leader in the defense and commercial markets, delivering state-of-the-art technologies and systems in all domains. Mr. Weiss joined IAI in 1998, after serving in Israel’s navy for 27 years in various field and headquarter positions. He retired from service in 1998 as a Navy Captain. While at IAI Mr. Weiss held a number of managerial positions...

Continue reading

Nano Dimension Appoints a New Chairman

Seasoned Executive Ofir Baharav will replace Avi Reichental as Nano Dimension’s ChairmanNESS ZIONA, Israel, Dec. 26, 2019 (GLOBE NEWSWIRE) — Nano Dimension Ltd., a leading Additively Manufactured Electronics (AME) provider (NASDAQ, TASE: NNDM), announced today that Mr. Ofir Baharav will replace its retiring Chairman of the Board, Mr. Avi Reichental, following his resignation from the company’s board of directors, effective December 24, 2019.Mr. Ofir Baharav has been serving on the board of directors of Nano Dimension since October 2015. He is a partner and executive in Stratus Venture Group Florida. He founded and ran 3D printing and semiconductors companies, operating in the United States, China, Japan, Korea and Europe. He is a named inventor on over 10 patents in software and hardware.Mr. Baharav was a VP...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.